Delivery Order SPE2DB22D2006-SPE2DB25FV6DT

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,212.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of testosterone cypionate 200 mg/mL, a specialty medication. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of testosterone cypionate 200 mg/ml. The delivery order, valued at $2,382.34, has a firm fixed price and is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999, which covers a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,177.00 firm fixed-price delivery order is for the supply of testosterone cypionate 200 mg/mL medication. The award has a ceiling value of $1,177.00 and an ultimate completion date of November 20, 2024. This contract is not designated with a set-aside. Amerisourcebergen Drug Corp, a for-profit organization, is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,006.75 firm fixed-price delivery order is for the supply of 200 mg/mL testosterone cypionate, a prescription medication. The contract has a completion date of September 26, 2024 and was awarded on September 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of testosterone cypionate 200 mg/mL medication. The contract has a firm fixed price of $1,378.62 and a completion date of May 15, 2024. It is not associated with any set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,925.44 firm fixed-price delivery order, awarded on November 12, 2021, is for the supply of Testosterone Cypionate 200 mg/mL medication. The contract has an ultimate completion date of November 15, 2021 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract provides for the delivery of testosterone cypionate 200 mg/mL, a specialty pharmaceutical product, with a ceiling value of $1,804.60 and a performance period through March 14, 2024. The award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Testosterone Cypionate 200 mg/mL. The contract, valued at $2,240.67, was awarded by the Defense Logistics Agency (DLA) and has a completion date of December 3, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. No set-aside designation was used for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,351.65 firm fixed-price delivery order is for the supply of testosterone cypionate 200 mg/mL, a specialty medication. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,447.54 firm fixed-price contract is for the supply of testosterone cypionate 200 mg/mL, with a period of performance through March 29, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV6DT
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of testosterone cypionate 200 mg/mL medication. The $1,923.50 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) on November 8, 2024 and has an ultimate completion date of November 12, 2024. This appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The IDC enables the DLA to efficiently procure a range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and other critical medical commodities, to support military healthcare programs globally. No set-aside designation was used for this particular award.

Generated 2/7/25, 9:14 AM